Drawing for ACSET

USPTO serial 87328579

ACSET

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCBRIDE, THEODORE M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACSET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

bin lu

BIN LU IP BUSINESS SOLUTIONS, LLC2200 CLARENDON BLVD. #1400 P.O. BOX 527ARLINGTON, VA 22201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005(Based on Intent to Use) Culture fluids for cultivating Oral mucosal cells; Culture media for cultivating Oral mucosal cells; Medical diagnostic reagents; Reagents and media for medical and veterinary diagnostic purposes(Based on 44(d) Priority Application) Culture fluids for cultivating Oral mucosal cells; Culture media for cultivating Oral mucosal cells; Medical diagnostic reagents; Reagents and media for medical and veterinary diagnostic purposesACTIVE—
010(Based on Intent to Use) Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing(Based on 44(d) Priority Application) Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testingACTIVE—
040(Based on Intent to Use) Treatment of materials by means of Oral mucosal cells kits; Treatment of materials in the nature of Oral mucosal cells(Based on 44(d) Priority Application) Treatment of materials by means of Oral mucosal cells kits; Treatment of materials in the nature of Oral mucosal cellsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 22, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 22, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 20, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 23, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 23, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 3, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 14, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 11, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 11, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 23, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
May 5, 2017FIXDELECTRONIC RECORD REVIEW COMPLETE—
Apr 28, 2017ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 20, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2017DOCKASSIGNED TO EXAMINER—
Feb 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 13, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance